AEM vs HDSN

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

HDSN exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY EPS decline of 116.7%. While the company maintains a clean balance sheet with very low debt (D/E 0.02) and trades below its Graham Number ($6.98), the divergence between strong revenue growth (28.2%) and negative operating margins (-16.23%) suggests an unsustainable operational model. Insider selling and a bearish technical trend further undermine the optimistic analyst target of $9.00.